| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 24,7 k € | +328.1% | 5,8 k € | -75.4% | 23,4 k € | +38.2% | 17,0 k € | +286.6% | -9,1 k € | -127.1% | 33,6 k € | +33.8% | 25,1 k € | +58.8% | 15,8 k € | -80.6% | 81,5 k € | +36.8% | 59,6 k € | +3.2% | 57,7 k € | +92.6% | 30,0 k € | +49.0% | 20,1 k € | +82.8% | 11,0 k € | +58.4% | 6,9 k € | |
| EBITDA | 24,0 k € | +369.2% | 5,1 k € | -77.6% | 22,8 k € | +39.3% | 16,4 k € | +267.8% | -9,8 k € | -129.6% | 33,0 k € | +34.1% | 24,6 k € | +61.8% | 15,2 k € | -81.1% | 80,7 k € | +36.7% | 59,0 k € | +3.2% | 57,2 k € | +94.3% | 29,4 k € | +50.7% | 19,5 k € | +87.2% | 10,4 k € | +61.1% | 6,5 k € | |
| Operating profit | 20,0 k € | +2028.8% | 939,7 € | -94.4% | 16,9 k € | +57.7% | 10,7 k € | +169.7% | -15,4 k € | -154.4% | 28,3 k € | +39.6% | 20,3 k € | +70.9% | 11,9 k € | -62.2% | 31,3 k € | -42.3% | 54,3 k € | +15.5% | 47,0 k € | +116.0% | 21,8 k € | +24.2% | 17,5 k € | +107.9% | 8,4 k € | +50.9% | 5,6 k € | |
| Profit/loss | 12,3 k € | +950.3% | -1,4 k € | -111.7% | 12,4 k € | +30.5% | 9,5 k € | +156.1% | -16,9 k € | -199.5% | 17,0 k € | +61.6% | 10,5 k € | +80.5% | 5,8 k € | -70.5% | 19,8 k € | -13.6% | 22,9 k € | +145.8% | 9,3 k € | -45.8% | 17,2 k € | +93.7% | 8,9 k € | +68.8% | 5,3 k € | +59.4% | 3,3 k € | |
| Equity | 61,9 k € | -5.6% | 65,5 k € | -2.2% | 67,0 k € | -4.1% | 69,8 k € | -12.5% | 79,8 k € | -17.5% | 96,7 k € | +21.4% | 79,7 k € | -7.7% | 86,3 k € | -15.3% | 101,9 k € | +24.1% | 82,1 k € | +38.8% | 59,1 k € | +18.7% | 49,8 k € | +52.8% | 32,6 k € | +37.5% | 23,7 k € | +28.5% | 18,5 k € | |
| Total assets | 112,9 k € | +9.2% | 103,3 k € | -14.6% | 121,0 k € | -4.3% | 126,4 k € | +8.2% | 116,8 k € | -18.4% | 143,2 k € | -6.1% | 152,4 k € | -1.2% | 154,3 k € | +4.8% | 147,2 k € | +8.4% | 135,8 k € | -13.6% | 157,2 k € | +43.7% | 109,3 k € | +32.6% | 82,4 k € | +14.2% | 72,2 k € | +108.8% | 34,6 k € | |
| Cash | 45,6 k € | +121.1% | 20,6 k € | -29.5% | 29,2 k € | -40.6% | 49,2 k € | +76.6% | 27,9 k € | -41.6% | 47,7 k € | +7.9% | 44,2 k € | -5.4% | 46,7 k € | -15.2% | 55,1 k € | +125.1% | 24,5 k € | -45.0% | 44,5 k € | +318.3% | 10,6 k € | -54.4% | 23,4 k € | -18.1% | 28,5 k € | +127.1% | 12,6 k € | |
| Debts | 20,3 k € | +186.0% | 7,1 k € | -69.6% | 23,3 k € | -10.2% | 26,0 k € | +306.3% | 6,4 k € | -59.7% | 15,9 k € | -62.7% | 42,5 k € | +11.8% | 38,0 k € | +148.0% | 15,3 k € | -35.5% | 23,8 k € | -64.5% | 67,0 k € | +12.6% | 59,5 k € | +35.8% | 43,8 k € | -9.6% | 48,5 k € | +200.7% | 16,1 k € | |
Private limited company · Pelt · incorporated on 26/01/2010
Private limited company profitable and well capitalised. Cash position rising (+121.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
HUVESEARCH is a Private limited company incorporated in 2010. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Pelt.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette